# Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

> **NCT01442194** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 3076 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** other disease-modifying therapy
- **DRUG:** Fingolimod

## Key facts

- **NCT ID:** NCT01442194
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-01
- **Primary completion:** 2020-07-10
- **Final completion:** 2020-07-10
- **Target enrollment:** 3076 (ACTUAL)
- **Last updated:** 2022-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01442194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01442194, "Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01442194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*